Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
Nordic Bioscience, Copenhagen (Denmark)
4 More presentations in this session
Doctor R. Klingenberg (Frankfurt, DE)
Doctor G. Vergaro (Pisa, IT)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
You may be interested in
Congress Presentation
